Financials Body and Mind Inc. Canadian Securities Exchange
Equities
BAMM
US09689V1008
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 CAD | -9.09% | -9.09% | +17.65% |
03-26 | Body and Mind Narrows Fiscal Q2 Loss | MT |
03-25 | Body and Mind Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 | CI |
Valuation
Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 14.26 | 66.89 | 24.73 | 38.18 | 11.37 | 11.88 |
Enterprise Value (EV) 1 | 16.11 | 57.88 | 26.01 | 38.7 | 23.04 | 30.26 |
P/E ratio | -6.53 x | -12.7 x | -5.44 x | -16.8 x | -0.39 x | -0.52 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 5.91 x | 14.5 x | 4.68 x | 1.49 x | 0.36 x | 0.52 x |
EV / Revenue | 6.68 x | 12.5 x | 4.92 x | 1.51 x | 0.73 x | 1.33 x |
EV / EBITDA | -14.9 x | -23.6 x | -5.18 x | 15.3 x | -17.9 x | -5.16 x |
EV / FCF | -10.1 x | -27.6 x | -8.48 x | 10.2 x | 16.7 x | -15.2 x |
FCF Yield | -9.91% | -3.62% | -11.8% | 9.84% | 6% | -6.57% |
Price to Book | 1.32 x | 2.02 x | 0.74 x | 1.11 x | 1.18 x | -1.16 x |
Nbr of stocks (in thousands) | 47,775 | 97,273 | 107,514 | 109,078 | 113,669 | 146,637 |
Reference price 2 | 0.2985 | 0.6876 | 0.2300 | 0.3500 | 0.1000 | 0.0810 |
Announcement Date | 11/13/18 | 11/13/19 | 12/15/20 | 11/18/21 | 1/17/23 | 11/14/23 |
Income Statement Evolution (Annual data)
Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 2.413 | 4.612 | 5.287 | 25.7 | 31.64 | 22.82 |
EBITDA 1 | -1.081 | -2.455 | -5.025 | 2.537 | -1.284 | -5.868 |
EBIT 1 | -1.151 | -2.744 | -5.481 | 0.6487 | -3.52 | -7.67 |
Operating Margin | -47.69% | -59.5% | -103.66% | 2.52% | -11.12% | -33.61% |
Earnings before Tax (EBT) 1 | -2.686 | -3.753 | -4.464 | 0.1902 | -25.63 | -18.15 |
Net income 1 | -1.781 | -3.753 | -4.341 | -2.261 | -28.68 | -20.78 |
Net margin | -73.81% | -81.37% | -82.09% | -8.8% | -90.64% | -91.07% |
EPS 2 | -0.0457 | -0.0540 | -0.0423 | -0.0208 | -0.2556 | -0.1547 |
Free Cash Flow 1 | -1.596 | -2.097 | -3.066 | 3.81 | 1.383 | -1.99 |
FCF margin | -66.14% | -45.46% | -57.99% | 14.82% | 4.37% | -8.72% |
FCF Conversion (EBITDA) | - | - | - | 150.17% | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 11/13/18 | 11/13/19 | 12/15/20 | 11/18/21 | 1/17/23 | 11/14/23 |
Balance Sheet Analysis
Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 1.85 | - | 1.28 | 0.53 | 11.7 | 18.4 |
Net Cash position 1 | - | 9 | - | - | - | - |
Leverage (Debt/EBITDA) | -1.712 x | - | -0.2554 x | 0.2075 x | -9.093 x | -3.133 x |
Free Cash Flow 1 | -1.6 | -2.1 | -3.07 | 3.81 | 1.38 | -1.99 |
ROE (net income / shareholders' equity) | -32.1% | -17.1% | -13.8% | -5.84% | -127% | -5,308% |
ROA (Net income/ Total Assets) | -8.98% | -6.63% | -9.13% | 0.93% | -5.56% | -18.4% |
Assets 1 | 19.84 | 56.61 | 47.54 | -242.4 | 515.9 | 113.2 |
Book Value Per Share 2 | 0.2300 | 0.3400 | 0.3100 | 0.3100 | 0.0800 | -0.0700 |
Cash Flow per Share 2 | 0.0100 | 0.0900 | 0.0100 | 0.0700 | 0.0200 | 0.0100 |
Capex 1 | 0.56 | 0.37 | 0.87 | 0.4 | 0.83 | 0.99 |
Capex / Sales | 23.39% | 7.98% | 16.49% | 1.57% | 2.62% | 4.35% |
Announcement Date | 11/13/18 | 11/13/19 | 12/15/20 | 11/18/21 | 1/17/23 | 11/14/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+41.06% | 6.19B | |
-15.95% | 4.48B | |
+6.36% | 3.29B | |
-11.34% | 3.12B | |
-3.12% | 2.5B | |
+45.41% | 1.94B | |
-7.74% | 1.68B | |
-0.67% | 1.64B | |
-11.32% | 1.56B |
- Stock Market
- Equities
- BMMJ Stock
- BAMM Stock
- Financials Body and Mind Inc.